LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 112 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $392,085 | -69.0% | 359,711 | -35.0% | 0.00% | – |
| Q2 2023 | $1,266,388 | +80.4% | 553,008 | +91.4% | 0.00% | – |
| Q1 2023 | $702,120 | +38.0% | 288,938 | +8.5% | 0.00% | – |
| Q4 2022 | $508,741 | -12.0% | 266,357 | +10.6% | 0.00% | – |
| Q3 2022 | $578,000 | +49.4% | 240,921 | +15.8% | 0.00% | – |
| Q2 2022 | $387,000 | +1.6% | 208,025 | +13.9% | 0.00% | – |
| Q1 2022 | $381,000 | -38.6% | 182,671 | +16.0% | 0.00% | – |
| Q4 2021 | $621,000 | +43.8% | 157,482 | +75.1% | 0.00% | – |
| Q3 2021 | $432,000 | +32.5% | 89,913 | +26.7% | 0.00% | – |
| Q2 2021 | $326,000 | -14.7% | 70,988 | +9.1% | 0.00% | – |
| Q1 2021 | $382,000 | +52.8% | 65,059 | -11.3% | 0.00% | – |
| Q4 2020 | $250,000 | +23.2% | 73,356 | -48.2% | 0.00% | – |
| Q3 2020 | $203,000 | -80.3% | 141,495 | -72.6% | 0.00% | – |
| Q2 2020 | $1,029,000 | +162.5% | 516,142 | +156.4% | 0.00% | – |
| Q1 2020 | $392,000 | -34.6% | 201,319 | +39.4% | 0.00% | – |
| Q4 2019 | $599,000 | +8.1% | 144,392 | -21.6% | 0.00% | – |
| Q3 2019 | $554,000 | -24.9% | 184,112 | +56.9% | 0.00% | – |
| Q2 2019 | $738,000 | +14.6% | 117,311 | +1.2% | 0.00% | – |
| Q1 2019 | $644,000 | -7.7% | 115,899 | +10.3% | 0.00% | – |
| Q4 2018 | $698,000 | -40.3% | 105,093 | -4.2% | 0.00% | – |
| Q3 2018 | $1,170,000 | -15.5% | 109,658 | -5.0% | 0.00% | – |
| Q2 2018 | $1,385,000 | +139.6% | 115,388 | +71.0% | 0.00% | – |
| Q1 2018 | $578,000 | -56.4% | 67,489 | -49.7% | 0.00% | – |
| Q4 2017 | $1,326,000 | -75.2% | 134,242 | -69.1% | 0.00% | -100.0% |
| Q3 2017 | $5,338,000 | +142.1% | 434,336 | +224.0% | 0.00% | +100.0% |
| Q2 2017 | $2,205,000 | +35.4% | 134,043 | +17.9% | 0.00% | – |
| Q1 2017 | $1,629,000 | -30.7% | 113,664 | -33.1% | 0.00% | -100.0% |
| Q4 2016 | $2,350,000 | +5.4% | 169,908 | +37.8% | 0.00% | 0.0% |
| Q3 2016 | $2,229,000 | -45.1% | 123,327 | -56.4% | 0.00% | – |
| Q2 2016 | $4,061,000 | -50.6% | 283,010 | -58.9% | 0.00% | -100.0% |
| Q1 2016 | $8,221,000 | -22.1% | 687,836 | -13.2% | 0.00% | +50.0% |
| Q4 2015 | $10,547,000 | +37.2% | 792,476 | +10.7% | 0.00% | -33.3% |
| Q3 2015 | $7,687,000 | +4343.4% | 715,705 | +3228.7% | 0.00% | – |
| Q2 2015 | $173,000 | – | 21,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |